4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001179110-20-012070
EVP/Chief Scientific Officer sold 10,000 shares at an average $63.22 ($632,156)
- EVP/Chief Scientific Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Albright Charles · EVP/Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-15 | Exercise or conversion : show line 1 in the form | +10,000 | $16.51 | $165,100 | 34,907 | D |
| 2020-12-15 | Sale : show line 2 in the form | −5,776 | $62.74 | $362,386 | 29,131 | D |
| 2020-12-15 | Sale : show line 3 in the form | −4,024 | $63.84 | $256,892 | 25,107 | D |
| 2020-12-15 | Sale : show line 4 in the form | −200 | $64.39 | $12,878 | 24,907 | D |
| Open-market sales · 10,000 sh · avg $63.22 · $632,156 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-15 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −10,000 | 145,000 | D |
Loading xslF345X03/edgar.xml…